PHIO FY 2024 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$4M

Operating Income

-$7M

Net Income

-$7M

EPS (Diluted)

$-0.91

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$147,000

Balance Sheet

Total Assets

$6M

Total Liabilities

$1M

Stockholders' Equity

$5M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$4M	-$6M	+42.5%
Operating Income	-$7M	-$11M	+31.8%
Net Income	-$7M	-$11M	+34.0%